Clinical trials for Soft tissue sarcomas

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Soft tissue sarcomas. For all clinical trials, go to clinical trials search

This list shows clinical trials for Soft tissue sarcomas

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Soft tissue sarcomas
Title Recruitment status Location
An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma Recruiting United Kingdom
TRUSTS: A phase IIb/III multicenter study comparing the efficacy of TRabectedin administered as a 3-hour or 24-hour infusion to doxorubicin in patients with advanced or metastatic Untreated Soft Tissue Sarcoma - TRUSTS Not Recruiting United Kingdom
A Phase III multicenter, international, randomized, double-blind, placebo-controlled study of doxorubicin plus palifosfamide-tris vs. doxorubicin plus placebo in patients with front-line metastatic soft tissue sarcoma - PICASSO III Not Recruiting United Kingdom
Multicenter parallel phase II trial of BI 2536 administered as one hour i.v. infusion every 3 weeks in defined cohorts of patients with various solid tumours. A new drug screening program of the EORTC Network of Core Institutions (NOCI) - Phase II trial of BI 2536 in pts with various solid tumors Not Recruiting United Kingdom
Multi-center, open-label, non-randomised phase II study to evaluate the activity and tolerability of GW786034 in patients with advanced and/or metastatic soft tissue sarcoma who have relapsed following standard therapies or for whom no standard therapy exists. Not Recruiting United Kingdom
A study of Avastin (Bevacizumab) in Combination with Standard Chemotherapy in Children and Adolescents with Sarcoma Not Recruiting United Kingdom
Un estudio multicéntrico de fase IIb/III que compara la eficacia de trabectedin administrado como una infusión de 3 horas o de 24 horas con doxorubicin en pacientes con sarcoma de tejidos blandos no tratado avanzado o metastático. A phase IIb/III multicenter study comparing the efficacy of trabectedin administered as a 3-hour or 24-hour infusion to doxorubicin in patients with advanced or metastatic Untreated Soft Tissue Sarcoma. - TRUSTS Not Recruiting United Kingdom
A randomized double blind phase III trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy. - PALETTE Not Recruiting United Kingdom
A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy. - PALETTE Not Recruiting United Kingdom
A Study of AVE8062 in Advancedstage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies Not Recruiting United Kingdom

Page last reviewed:

Next review due: